Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Budhram

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 6, 2020
Understanding the application of diagnostic criteria for multiple sclerosis helps prevent misdiagnosisAdrian Budhram
Neurology|June 7, 2017
Letter re: Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAdrian Budhram
Neurology|March 18, 2020
Reader response: A multicenter comparison of MOG-IgG cell-based assaysAdrian Budhram
Neurology|May 23, 2018
Reader response: Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseasesAdrian Budhram
The Lancet Regional Health. Western Pacific|August 21, 2023
Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthroughAdrian Budhram
Annals of Clinical and Translational Neurology|May 14, 2025
Letter to: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based AssayAdrian Budhram
Neurology|July 31, 2024
Reader Response: Recurrent Rhombencephalitis Associated With Anti-GAD65 AntibodyAdrian Budhram
Multiple Sclerosis and Related Disorders|March 11, 2024
Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the backgroundAdrian Budhram
Frontiers in Neurology|June 7, 2022
Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune MyelopathySamir Alkabie, Adrian Budhram
Multiple Sclerosis and Related Disorders|November 11, 2025
Examining diagnostic performance of the 2023 MOGAD criteria: Lessons learned and future directionsAdrian Budhram, Kamala Sangam
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 6, 2020
Understanding the application of diagnostic criteria for multiple sclerosis helps prevent misdiagnosisAdrian Budhram
Neurology|June 7, 2017
Letter re: Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAdrian Budhram
Neurology|March 18, 2020
Reader response: A multicenter comparison of MOG-IgG cell-based assaysAdrian Budhram
Neurology|May 23, 2018
Reader response: Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseasesAdrian Budhram
The Lancet Regional Health. Western Pacific|August 21, 2023
Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthroughAdrian Budhram
Annals of Clinical and Translational Neurology|May 14, 2025
Letter to: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based AssayAdrian Budhram
Neurology|July 31, 2024
Reader Response: Recurrent Rhombencephalitis Associated With Anti-GAD65 AntibodyAdrian Budhram
Multiple Sclerosis and Related Disorders|March 11, 2024
Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the backgroundAdrian Budhram
Frontiers in Neurology|June 7, 2022
Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune MyelopathySamir Alkabie, Adrian Budhram
Multiple Sclerosis and Related Disorders|November 11, 2025
Examining diagnostic performance of the 2023 MOGAD criteria: Lessons learned and future directionsAdrian Budhram, Kamala Sangam
Pageof 12